Top Massachusetts Pharmaceutical Startups (67)
Formation Bio is a tech-driven pharma company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes all aspects of drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data capture. Formation Bio acquires clinical-stage drugs from pharma and biotech and develops them faster and more efficiently, unlocking greater...
We’re an innovative and forward-thinking Commercial Pharma analytics startup based in the UK. Since 2014 we’ve been focusing our efforts on providing cutting edge input to pharmaceutical organisations throughout Europe and North America. By combining years of experience in healthcare, pharmaceutical and data , we provide a powerful tool for acquiring real actionable insights to Commercial strategy, Formulary status, Salesforce...
X4 Pharmaceuticals develops and commercializes therapies for rare diseases of the immune system, with a focus on rare hematology conditions and significant unmet needs. Its expertise includes immune-system and CXCR4 biology. The company developed mavorixafor, an orally available CXCR4 antagonist marketed in the United States as XOLREMDI for WHIM syndrome, and is advancing it in a global Phase 3 trial...
Solid Biosciences is a precision genetic medicine company developing gene therapy candidates for rare neuromuscular and cardiac diseases. Its pipeline includes programs for Duchenne muscular dystrophy, Friedreich’s ataxia, catecholaminergic polymorphic ventricular tachycardia, and genetic cardiomyopathies. The company also develops genetic regulators and other enabling technologies intended to improve gene-therapy delivery. Founded by people directly affected by Duchenne, its mission is...
Seismic Therapeutic is a clinical-stage biotechnology company developing biologic medicines for autoimmune and inflammatory diseases. Its IMPACT platform integrates machine learning with structural biology, protein engineering and translational immunology to discover and optimize novel therapies targeting dysregulated adaptive immunity. The company seeks to accelerate biologics development and create medicines with improved therapeutic properties for patients with immune-driven conditions.
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie...
Invivyd is a biopharmaceutical company on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2. Invivyd’s technology works at the intersection of evolutionary virology, predictive modeling, and antibody engineering, and is designed to identify high-quality, long-lasting antibodies with the potential to resist viral escape. The...
Rapport Therapeutics aims to transform the treatment of neurological disorders through a precision medicine approach, precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). With this approach, Rapport can overcome the well-established limitations of today’s neuromedicines that act indiscriminately throughout the nervous system, resulting in suboptimal efficacy and burdensome side effects. Leading the hunt for precision medicines is a team...
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader medicines for serious diseases, including oncology, autoimmune, inflammatory, cardiovascular, and cardiometabolic conditions. Its QuEEN platform combines proprietary molecular glue libraries with proteomics, structural biology, computational chemistry, and AI/machine learning to discover and develop treatments aimed at disease-driving proteins and pathways long considered undruggable across multiple therapeutic...
We are building AI to expand the boundaries of medicine. Our quantum chemistry AI platform, powered by an industry-leading chemoproteomics data generation engine, learns the rules of molecular reactivity making programmable small molecule drug design a reality. With any protein target now within reach, we are generating a pipeline of potential first-in-class candidates, starting with unmet needs in oncology, immunology...
PDC Pharmacy is a long-term care pharmacy that provides specialized pharmaceutical services for individuals with intellectual disabilities, autism, and behavioral health needs, exclusively serving provider agencies.
Mariana Oncology, a Novartis company, is a fully integrated next generation radiopharmaceutical company that brings together experts in ligand discovery, radiochemistry, radiobiology and oncology translational and clinical research in order to build a pipeline across a range of solid tumor types. Our mission at Mariana is to discover and develop safe, effective, and highly targeted radiopharmaceuticals.
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on...
Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases. Founded by physician-scientists, the company leverages expertise in cardiovascular signaling pathways to advance groundbreaking clinical programs in PDE9 and CaMKII inhibition, aiming to address unmet patient needs and transform the course of cardiovascular...
Phosphorex is a leading contract development and manufacturing organization (CDMO) that empowers innovators to advance complex therapeutics through innovative drug delivery platforms, including lipid nanoparticles (LNPs), polymeric nanoparticles (PNPs), and polymeric microspheres. By integrating scientific creativity, formulation optimization, and scalable process development, they help emerging and established biopharma teams move next-generation therapeutics from initial proof-of-concept through preclinical development and into...
Skyhawk Therapeutics is a clinical-stage biotechnology company that discovers and develops small-molecule therapeutics designed to modify RNA expression. Its pipeline comprises RNA-modifying drug candidates for diseases including neurodegenerative and neuromuscular disorders, oncology, fibrosis, and other conditions. The company’s mission is to improve disease treatment for patients worldwide by developing medicines that target RNA, with the goal of addressing challenging diseases.
Korro Bio is a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA. By leveraging its proprietary Oligonucleotide Promoted Editing of RNA (OPERA) platform, the company aims to discover and develop therapies for rare and highly prevalent diseases. Korro Bio harnesses the body's natural RNA editing machinery to make precise, single-base edits, addressing...
Multiply Labs develops advanced robotic systems that manufacture individualized drugs at scale. Our products are enabled by the combination of pharmaceutical science with robotics technology. Multiply Labs has built and operates a unique robotic pharmaceutical manufacturing facility in San Francisco.



























